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1. Introduction 
Donor selection for allografting of a non-paired vital organ, such as the heart, is necessarily 
limited to cadaveric or possibly xenogeneic sources. In contrast, because of the presence in 
most normal persons of two kidneys – each with a physiological reserve capable of 
providing four times the minimal required function – renal transplantation has become an 
accepted medical procedure using cadaveric and living related or unrelated volunteers as 
organ sources.  
Each of these donor categories presents unique ethical, legal and social implications (Spital, 
1991; Woo, 1992). 
That must be addressed carefully to protect not only the health and rights of the recipient 
but also those of the donor. 
Of equal importance are the medical aspects of donor evaluation and the technical features 
of the nephrectomy procedure.  
The initial functional capacity of the transplanted kidney is largely independent of 
immunological factors; however, it is highly dependent on the efficacy of donor preparation 
and procurement techniques in preventing ischemic injury.  
It has been necessary to adapt the surgical procedures to develop combination procurement 
techniques that provide equal protection for the extra renal organs as well as the kidneys.  
2. Living kidney donor 
The first successful renal transplant was performed in 1954. With the development of 
effective immunosuppressive regimens, this observation was extended to less compatible 
intrafamilial donors and eventually to unrelated donors. 
Until the early 1980s, many dialysis patients had doubt to heed cadaver donor 
transplantation because its morbidity and mortality rates were manifold. 
With the introduction of calcineurin inhibitors, monoclonal and polyclonal antibody 
immunosuppression and other new immunosuppressive agents into clinical regimens, the 
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Living related donor grafts still have a 10 to 12 % better survival rate at 1 year and a 
significantly higher probability of function thereafter, however (Cecka and Terasaki, 1998).  
Family members as suitable organ donors were recommended. (Delmonico et al., 1990). 
The experience of using living unrelated kidneys in transplantation has shown that these 
organs have a graft survival profile that, in fact approaches that of related donors (Terasaki 
et al., 1995).  
Even with the current widespread application of calcineurin inhibitors and monoclonal 
and polyclonal antibody immunosuppression, there is a persisting biological advantage of 
living donor kidneys (living related donor or living unrelated donor) over cadaver donor 
allograft.  
Although short – term graft survival after transplantation from both donor sources is 
excellent, the 5 year success rate of greater than 80 % that can be attained using living donor 
kidneys exceeds  by 10 to15% of any reported cadaver  donor results. 
Another justification for using living donors is that the operation can be specifically 
planned, limiting waiting time on dialysis.  
Of greater importance is the ability to perform the transplant when the recipient is in 
optimal medical condition. This ability is particularly pertinent for diabetic patients, whose 
condition may deteriorate rapidly on dialysis. Finally, there is the risk that the patient may 
develop antibody to HLA antigens during prolonged dialysis, especially if intermittent 
blood transfusions are required.  
The final reason for the continued expansion of living donor transplantation is the 
insufficient supply of cadaver donor organs required to fulfill the needs of renal failure 
victims awaiting transplantation (Cohen et al., 1998).  
For each 1 million of the population, approximately 75 to 80 renal transplants would have 
to be performed annually to keep pace with the more than 100 new patients diagnosed 
with end – stage renal disease and previous transplant recipients whose allograft 
eventually fail.  
Even in areas with outstanding cadaver donor retrieval rates or with less strict criteria for 
donor selection (Kauffman et al., 1997), the number of potential recipients greatly exceeds 
the supply of donor’s kidneys. A steadily growing population of patients is being 
maintained on dialysis in most areas of the world.  
With the extension of minimally invasive techniques to living kidney donation the potential 
adverse impact of the operation has become less significant.  
Although, it was thought that laparoscopic nephrectomy for renal transplantation might 
have some adverse effects to the donor organ because of prolonged warm ischemic interval, 
it is known that laparoscopic donor nephrectomy leads to decreases analgesic dose, 
decreased length of hospitalization, early return to normal daily activity and less surgical 
morbidity. 
Nowadays, new devices are used in laparoscopic nephrectomy, have led to shorten ischemic 
time. So that its results are now comparable to those achieved after classic open 






Laparosopic donor nephrectomy (LDN) has become the preferred technique for live donor 
nephrectomy at most transplant centers in the United States (Ratner et al, 1999; Jacobs et al, 
2004). 
Survival studies indicate that the 5 year life expectancy of a unilaterally nephrectomized 35 
year – old male donors is 99 % compared with 99.3 % normal expectation (Merrill, 1964). 
The quality of life after kidney donation has been reported in 979 patients who had donated 
a kidney for transplantation (Johnson et al., 1997). Most of the responders had an excellent 
quality of life.  
Multivariate analysis of those who did not respond favorably identified the following two 
factors for negative psychosocial outcome; relatives other than first degree and recipients 
who died within 1 year of transplantation.  
Concern has been raised that healthy human donors might develop hypertension and renal 
dysfunction years after unilateral nephrectomy. Follow – up studies of hundreds of living 
donors for 20 years have been unable, however, to identify any convincing evidence of long 
– term functional abnormalities associated with unilateral nephrectomy (Najarian et. al., 
1992). 
Regarding to these considerations, living donors continue to be the significant proportion of 
that donor pool. The proportion varies from less than 5% in some areas to 100% in areas 
where cadaver donor transplantation is unavailable. At present in U.S. about 27% of 
transplanted kidneys are obtained from living donors. 
3. Medical evaluation and selection of the living donor  
Advantages of transplant should be reasonable in comparison with its limited risks and both 
patient and donor should be justified for accepting it. 
All potential donors are first screened for emotional stability and motivation as well as 
blood group ABO typing.  
Incompatibility of ABO blood group between donor and recipient has resulted in irreversible 
rejection. Because of the extreme shortage of donor kidneys, especially for blood group O 
recipients, this requirement has been constantly reassessed. Several groups have reported 
successful results after transplantation of blood group A2 kidneys into group O recipients 
(Nelson et.al., 1998). Approximately 20% of blood group A persons are subtyped as A2. The 
highly successful transplantation of A2 kidneys into group O recipients has been explained by 
the low expression of A determinants in A2 kidneys compared with A1 kidneys.  
Potential donors remaining after initial screening process are evaluated to confirm excellent 
general health and bilateral renal function (kasiske et. al., 1996).The basic criteria for a renal 
donor are an absence of renal disease, an absence of transmissible malignancy, and an 
absence of active infection. 
Many of the studies are directed toward detection of exterarenal pathology. This medical 
evaluation may reveal significant but treatable problems of which the donor was unaware. 
(Table 1) (Ko, et al. 2001) 
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Family conference with transplant-dialysis team ABO blood group, tissue typing, 
leukocyte cross match, ± mixed lymphocyte culture 
History, physical examinations, serial blood pressure determinations 
Cell blood count, coagulation profile, BUN, serum creatinine, FBS, cytomegalovirus 
antibody, human immunodeficiency virus antibody, hepatitis B and C testing, cholesterol, 
triglycerides, calcium, phosphorus, urine analysis, urine culture, 24-hour urine protein 
Chest radiograph, intravenous pyelogram or ultrasound electrocardiogram
Aortogram or digital subtraction angiography and/or three-dimensional computed 
tomography 
Table 1. Evaluation of living donors. 
The remaining studies are concerned with the quality of renal function and the clarification 
of any anatomical abnormalities in either kidney. It must be determined that the non-
donated kidney is normal. 
Final selection of the donor, if several medically suitable relatives are available is made on 
the basis of histocompatibility testing. Selection also may be determined on the basis of age 
(avoiding elderly volunteers) or on less objective factors, such as the special social 
obligations of particular family member.  
It is now clear that living unrelated donor kidneys provide significant physiological and 
long term survival advantages and are being accepted with increasing frequency. In most 
centers donation for monetary compensation is not allowed (Childress, 1996; Quinibi 1997).  
The imaging of kidneys prior to nephrectomy performs by several methods, including: 
ultrasound (US); conventional angiography (CA); digital subtraction angiography (DSA); 
computed tomography (CT) and magnetic resonance imaging (MRI), each of which has innate 
problems. A single modality to assess vasculature, renal parenchyma and urinary drainage is 
preferred. The pre-nephrectomy anatomy which most anticipates complications during the 
transplant procedure is the presence or absence of variant arteries (Stephen Munn, 2010). 
For the living donor who has been identified by these criteria, the classic gold standard 
aortogram has been the final diagnostic study scheduled. The ability to visualize data 
obtained with CT or MRI in a three-dimensional method carefully reconstructing the 
images, isolating arteries, veins or parenchymal structures has assisted surgical planning. 
Surgical goals are to minimize warm ischemia time, to preserve renal vessels, and to 
preserve ureteral blood supply. 
Magnetic resonance imaging and angiography provide suboptimal information on renal 
vascular anatomy (Kok NF, et al., 2008). 
Arvine-Berod and et al compared the sensitivity of computed tomography angiography 
(CTA) and magnetic resonance angiography (MRA) in preoperative renal vascularisation in 
living kidney donors. They determined that MRA is less sensitive than CTA in living kidney 
donors especially in the detection of multiple renal arteries. (Arvine-Berod A, et al., 2011) 
4. Post operative care and complications 






Most of patients are ready for discharge from the hospital in 3 to 4 days and for return to 
employment by 4 weeks.  
Urine culture, renal function tests and a complete blood count are reassessed before 
discharge. The patient then has follow – up evaluations at increasing intervals.  
The perioperative mortality rate for kidney donors is estimated to be 0.30 % (kasiske et al., 
1996). Approximately 20 deaths have been reported after living donor allograft donation 
over 35 years (Jones et al., 1993). Other complications of the kidney donor procedure are 
generally minimal and easily remediable (Johnson et al., 1997).  
The current overall complication rate is approximately 2 % (Bia et al., 1995).  
Most complications occur in the perioperative period, with atelectasis, urinary infection, 
wound problems and prolonged bowel dysfunction accounting for the majority.  
One of the most dangerous complications is thrombophlebitis with possible life-threatening 
pulmonary embolus.  
Fatal cases of hepatitis, myocardial infarction and depression, leading to alcoholism have 
been reported.  
Longer term morbidity should be minimal. Endogenous creatinine clearance rates rapidly 
approach 70 to 80 % of the preoperative level, and reports of late renal failure have been 
extremely rare. An important factor is the exclusion during the selection process of 
pathology or potential pathology in the donors. 
The short and long – term morbidity of donor nephrectomy are generally considered to be 
low enough, and probability of successful graft outcome high enough, to make the risks 
acceptable for fully informed donors. 
The decrease of worsening donor and noticeable successful results of transplantation from 
unrelated living donors caused some centres became interested to donation from strangers 
(Spital, 1994). According to our experience, male donors have better prognosis and survival 
compared with females.  
5. Cadaver kidney donor 
If a suitable living donor is not available, most patients with end-stage renal failure should 
be considered for cadaveric renal transplantation, not only because transplantation is more 
cost-effective but also because true rehabilitation seldom is achieved on long-term dialysis 
(Evans et al., 1985). Although the long-term success rates remain inferior to those achieved 
with interfamilial transplantation, projections indicate that cadaver donor allograft currently 
have a 1-year graft survival rate of greater than 85% and graft half-life (time to loss of 50% of 
currently surviving grafts) has improved to at least 10 years (Cecka and Terasaki, 1998).   
Present methods of preservation may permit 72 hours maintenance of the cadaver donor 
kidney in a condition sufficiently viable to allow return of function after revascularization. 
Opportunities are present for evaluation of the physiological and bacteriological condition 
of the donor kidney and for pursuing histocompatility selection after the organ is removed 
from the cadaver. Because of these factors and increasingly widespread establishment of the 
definition of brain death guidelines that allow removal of organs that are more likely to be 
physiologically healthy, cadaver donor renal allograft continue to account for approximately 
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75% of reported transplants. The total number is limited only by the unsolved worldwide 
problem of persisting barriers to organ donation (Cohen et al., 1998). 
6. Evaluation of the potential cadaver kidney donor 
The ideal donor is a young, previously healthy individual who has sustained a fatal head 
injury or cerebrovascular accident.  
Transplantation of kidneys from small pediatric donors is possible, although the technical 
aspects are more exacting. When kidneys are obtained from a pediatric donor less than 3 
years of age, most groups recommend en bloc transplantation of both organs into a single 
adult recipient. We have reported a successful En Bloc bilateral kidney, Aorta, and Vena 
Cava Transplantation from a 3 years old deceased boy to an adult recipient in our center in 
Guilan University of Medical Sciences, Iran. (Fig. 1) (Mokhtari et al., 2010) 
 
Fig. 1. En-bloc kidneys after transplantation (recipient). After irreversibility of brain damage 
is established, maintenance of renal blood flow and function without any complication and 
adequate hydration is important. Minor terminal elevations of blood urea nitrogen and 
creatinine levels are not unusual and do not necessarily exclude the donor.  
A major concern for the donor team is the risk of transmitting infection with the allograft 
into an immunosuppressed recipient. 
Diagnosis of irreversible coma, or brain death, which has been recognized by neurologists 
and neurosurgeons, has presented a set of circumstances that of great potential benefit to 
patients needing organ allografts. The concept and definition of brain death do not depend 
in any way on transplantation.  
The discontinuation of respiratory support and other extraordinary therapy for patients 
who have been declared dead after careful assessment of brain function should be 
considered a humane and necessary act without regard to the possibility of such a person 






After extensive assessment of such patients, neurologists and neurosurgeons universally 
have agreed that once functional death of the brain stem occurs, there is no chance for 
partial recovery, and artificial support should be withdrawn.  
7. Nonhuman kidney donor 
The need for kidneys is growing steadily, whereas organ donation has leveled off or 
decreased in some regions. This situation has resulted in a rapidly escalating demand for 
medical and economic resources to support long-term peritoneal dialysis or hemodialysis 
programs. Because the supply of such resources is limited, constant efforts must be made to 
improve the efficacy and increase the number of transplants performed. The latter is 
determined primarily by the number of donor organs available.  
Nonhuman (xenogenetic) donors represent a possible alternative source of transplantable 
organs. Beginning in the earlry1900s, several isolated attempts were made on to transplant 
kidneys from various animal donors into patients with renal failure. If a successful approach 
to the use of such organs could be established, an unlimited pool of donors free of most of 
the legal and moral issues associated with the use of human organs could be made available. 
The major obstacle to such an approach has been the increased intensity of the rejection 
response elicited by the more diverse genetic relationship between donor and recipient (Ko, 
et al. 2001). 
For several reasons, there is renewed interest in the possibility that xenotransplantation 
could provide the solution for the shortage of human donor organs. The first reason for this 
enthusiasm is the increasingly successful use of genetic engineering to produce transgenic   
animals expressing recombinant molecules designed to moderate the immune response 
(Bhatti et al., 1999; Schmoeckel et al., 1998; Waterworth et al., 1998; Zaidi et al., 1998). 
Another reason for the renewed optimism regarding xenotransplantation has been the 
demonstration in preclinical primate models that tolerance of allograft can be produced 
without the need for long-term immunosuppression (Kirk et al., 1999).   
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